1. Yi, H, Geng, L, Black, A, Berim, L, Wang, J. 2017. The miR-487b-3p/GRM3/TGFβ signaling axis is an important regulator of colon cancer tumorigenesis. In Oncogene, 36, 3477-3489. doi:10.1038/onc.2016.499. https://pubmed.ncbi.nlm.nih.gov/28114282/
2. Neto, Ana, Ceol, Craig J. 2017. Melanoma-associated GRM3 variants dysregulate melanosome trafficking and cAMP signaling. In Pigment cell & melanoma research, 31, 115-119. doi:10.1111/pcmr.12610. https://pubmed.ncbi.nlm.nih.gov/28646617/
3. Harrison, P J, Lyon, L, Sartorius, L J, Burnet, P W J, Lane, T A. . The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia. In Journal of psychopharmacology (Oxford, England), 22, 308-22. doi:10.1177/0269881108089818. https://pubmed.ncbi.nlm.nih.gov/18541626/
4. Saini, S M, Mancuso, S G, Mostaid, Md S, Everall, I P, Bousman, C A. 2017. Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk. In Translational psychiatry, 7, e1196. doi:10.1038/tp.2017.172. https://pubmed.ncbi.nlm.nih.gov/28786982/
5. Lencer, Rebekka, Bishop, Jeffrey R, Harris, Margret S H, Keshavan, Matcheri S, Sweeney, John A. 2013. Association of variants in DRD2 and GRM3 with motor and cognitive function in first-episode psychosis. In European archives of psychiatry and clinical neuroscience, 264, 345-55. doi:10.1007/s00406-013-0464-6. https://pubmed.ncbi.nlm.nih.gov/24682224/
6. Gregory, J M, McDade, K, Livesey, M R, Chandran, S, Smith, C. 2020. Spatial transcriptomics identifies spatially dysregulated expression of GRM3 and USP47 in amyotrophic lateral sclerosis. In Neuropathology and applied neurobiology, 46, 441-457. doi:10.1111/nan.12597. https://pubmed.ncbi.nlm.nih.gov/31925813/
7. Egan, Michael F, Straub, Richard E, Goldberg, Terry E, Kleinman, Joel E, Weinberger, Daniel R. 2004. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. In Proceedings of the National Academy of Sciences of the United States of America, 101, 12604-9. doi:. https://pubmed.ncbi.nlm.nih.gov/15310849/
8. Ma, Ning, Liu, Xiaoling, Xing, Chen, Xiao, He, Wang, Renxi. 2015. Ligation of metabotropic glutamate receptor 3 (Grm3) ameliorates lupus-like disease by reducing B cells. In Clinical immunology (Orlando, Fla.), 160, 142-54. doi:10.1016/j.clim.2015.05.016. https://pubmed.ncbi.nlm.nih.gov/26071318/
9. Bishop, Jeffrey R, Miller, Del D, Ellingrod, Vicki L, Holman, Timothy. . Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia. In Human psychopharmacology, 26, 28-34. doi:. https://pubmed.ncbi.nlm.nih.gov/21344500/
智鼠故事 
